{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "fatty liver",
      "fibrosis",
      "infectious disease",
      "nonalcoholic steatohepatitis",
      "obesity"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34168043",
  "DateCompleted": {
    "Year": "2021",
    "Month": "07",
    "Day": "07"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "07",
    "Day": "07"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "e000568",
      "10.1136/bmjgast-2020-000568"
    ],
    "Journal": {
      "ISSN": "2054-4774",
      "JournalIssue": {
        "Volume": "8",
        "Issue": "1",
        "PubDate": {
          "Year": "2021",
          "Month": "Jun"
        }
      },
      "Title": "BMJ open gastroenterology",
      "ISOAbbreviation": "BMJ Open Gastroenterol"
    },
    "ArticleTitle": "Exercising in the COVID-19 era: implications in non-alcoholic fatty liver disease (NAFLD).",
    "Abstract": {
      "AbstractText": [
        "COVID-19 is a major public health pandemic. Risk factors for severe infection and poorer outcomes include cardiovascular disease, obesity, type 2 diabetes mellitus and non-alcoholic fatty liver disease (NAFLD). Lifestyle interventions, including diet and physical activity modifications, are the current recommended treatment for NAFLD. In this communication, the authors discuss the crossover link between NAFLD and severe COVID-19 infection and the impact of essential public health measures to suppress the spread of COVID-19 on exercise and physical activity participation in patients with NAFLD. The future of exercise prescription and the potential use of digital technology in addressing NAFLD healthcare needs in the COVID-19 era are also explored."
      ],
      "CopyrightInformation": "\u00a9 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ."
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0002-8948-1829"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "School of Physiotherapy, Royal College of Surgeons in Ireland, Dublin, Ireland."
          },
          {
            "Identifier": [],
            "Affiliation": "Discipline of Physiotherapy, Trinity College Dublin, Dublin, Ireland."
          }
        ],
        "LastName": "O'Gorman",
        "ForeName": "Philip",
        "Initials": "P"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Hepatology, St James's Hospital, Dublin, Ireland SNorris@stjames.ie."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Clinical Medicine, Trinity College Dublin, Dublin, Ireland."
          }
        ],
        "LastName": "Norris",
        "ForeName": "Suzanne",
        "Initials": "S"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "BMJ Open Gastroenterol",
    "NlmUniqueID": "101660690",
    "ISSNLinking": "2054-4774"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [
        "epidemiology",
        "prevention & control"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "epidemiology"
      ],
      "DescriptorName": "Cardiovascular Diseases"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Comorbidity"
    },
    {
      "QualifierName": [
        "epidemiology"
      ],
      "DescriptorName": "Diabetes Mellitus, Type 2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Diet, Healthy"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Exercise Therapy"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [
        "epidemiology",
        "therapy"
      ],
      "DescriptorName": "Non-alcoholic Fatty Liver Disease"
    },
    {
      "QualifierName": [
        "epidemiology"
      ],
      "DescriptorName": "Obesity"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Pandemics"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Physical Distancing"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Quarantine"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Risk Factors"
    },
    {
      "QualifierName": [],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Severity of Illness Index"
    }
  ],
  "CoiStatement": "Competing interests: None declared."
}